IPO Boutique Research, Color & More Information for Subscribers
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Recro Pharma, Inc. Symbol: REPH Price: Last trade $6.99 Trade Date: 12/13 Shares: 5.7 million Underwriter(s)Piper Jaffray Rating=Subscription Needed Company: Valley[…]
This past week five IPOs debuted, three updated terms and seven new deals were filed. Of the five deals that debuted this week, four needed to price significantly below their initial ranges in order to come to market. The single deal that was priced in-range, Pure Storage (NYSE: PSTG), opened $0.26 below its $17.00 IPO price[…]
Become a subscriber of IPOBoutique to obtain ratings and get real-time color of new IPOs building up to each of the companies debuts. There are one-time, monthly and annual plans available. Wednesday, October 7 Aclaris Therapeutics (Nasdaq: ACRS) Pure Storage, Inc. (NYSE: PSTG) Thursday, October 8 CytomX Therapeutics (Nasdaq: CTMX) Allegiance Bancshares (Nasdaq: ABTX) CPI[…]
An IPO rumored for weeks, Pure Storage (NYSE: PSTG), set terms on Thursday morning for a deal that is set to debut on October 7. Pure Storage transforms business through a dramatic increase in performance and reduction in complexity and costs. Their innovative technology replaces storage systems designed for mechanical disk with all-flash systems optimized[…]
Once again this week, there are currently no deals on the schedule set to debut. We continue to reiterate that this period is the traditional slow period or ‘lull’ in the IPO market. We would not at all be surprised to see company’s begin to set terms the week after Labor Day. One company with[…]
The IPO market is likely in hibernation mode until after Labor Day…allowing us to re-evaluate successful and broken IPOs and to digest the large amounts of data and news that presents itself with the stock market.